Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 399 entries
View as:

Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00084734 Org: User:
Start: 05/31/02 End: 12/31/09 Due: 12/31/10

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03599453 Org: User:
Start: 01/09/19 End: 03/21/23 Due: 03/21/24

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06307548 Org: User:
Start: 07/30/24 End: 06/01/27 Due: 06/01/28

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04696575 Org: User:
Start: 07/02/21 End: 07/01/26 Due: 07/01/27

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01834248 Org: User:
Start: 07/30/13 End: 03/21/16 Due: 03/21/17

Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00003115 Org: User:
Start: 06/30/96 End: 02/29/04 Due: 02/28/05

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02833506 Org: User:
Start: 12/08/17 End: 08/15/19 Due: 08/15/20

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002964 Org: User:
Start: 02/28/95 End: - Due: -

Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial

Phase: N/A Priority: Normal
NCT ID: NCT05338905 Org: User:
Start: 10/11/22 End: 10/11/27 Due: 10/11/28

Cholecalciferol and Flu Vaccine in Treating Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01561989 Org: User:
Start: 10/31/11 End: 06/30/15 Due: 06/30/16

Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus

Phase: N/A Priority: Normal
NCT ID: NCT01238042 Org: User:
Start: 03/31/03 End: 11/30/14 Due: 11/30/15

Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01108003 Org: User:
Start: 04/30/10 End: 10/31/15 Due: 10/31/16

Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01292668 Org: User:
Start: 03/31/11 End: 09/30/14 Due: 09/30/15

Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01003678 Org: User:
Start: 10/31/09 End: 10/31/13 Due: 10/31/14

Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00683787 Org: User:
Start: 05/31/08 End: 03/31/11 Due: 03/31/12

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01754519 Org: User:
Start: 05/31/13 End: 08/31/15 Due: 08/31/16

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT04298606 Org: User:
Start: 11/22/21 End: 11/22/29 Due: 11/22/30

Vitamin D in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00524680 Org: User:
Start: 06/30/07 End: 03/31/13 Due: 03/31/14

Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence

Phase: N/A Priority: Normal
NCT ID: NCT05587582 Org: User:
Start: 09/01/22 End: 01/07/25 Due: 01/07/26

Antioxidant Supplements, Genetics and Chemotherapy Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03413761 Org: User:
Start: 12/18/04 End: 11/12/13 Due: 11/12/14

Photodynamic Therapy in Treating Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01668823 Org: User:
Start: 02/29/04 End: 06/30/14 Due: 06/30/15

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06427369 Org: User:
Start: 10/01/24 End: 09/01/27 Due: 09/01/28

Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems

Phase: N/A Priority: Normal
NCT ID: NCT05423340 Org: User:
Start: 06/12/22 End: 10/03/24 Due: 10/03/25

Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)

Phase: N/A Priority: Normal
NCT ID: NCT05518032 Org: User:
Start: 10/01/24 End: 10/01/26 Due: 10/01/27

Fulvestrant in Treating Patients With Recurrent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00217464 Org: User:
Start: 06/30/04 End: 03/31/10 Due: 03/31/11